TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | -7 | -11 | -13 | -37 | -37 | -17 |
| S | %wins | 50 | 100 | 100 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/07 18:56 | 7/16/07 | HALO | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Ramsay David A | CA | O | Secretar | S | -99 | 9.89 | 6 | -10 | -3 | 371 | D | 445 | 291 | 27 | 9 | -7 | 9 | 1 | -1 | 1 | -5 | -13 | -6 | -32 | -23 |
6/15/07 16:59 | 6/14/07 | HALO | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Ramsay David A | CA | O | Secretar | S | -101 | 10.10 | 2 | -10 | -3 | 381 | D | 495 | 343 | 63 | 22 | -3 | -2 | -6 | -1 | -2 | -8 | -8 | -19 | -41 | -50 |
5/16/07 16:15 | 5/14/07 | HTI | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Ramsay David A | CA | O | Secretar | S | -102 | 10.19 | 0 | -10 | -2 | 391 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |